Evidence map›Paper›PMID 40047923›Full record

ArticleMedical microbiology and immunology2025

Stability of cytokine, cellular and clinical response to the intravenous LPS challenge repeated after one year: a healthy volunteer trial.

Anselm Jorda, Lena Pracher, Sabine Eberl, Alina Nussbaumer-Pröll, Maysa Sarhan, Maria Weber, Markus Wahrmann, Valentin Al Jalali, Felix Bergmann, Marlene Prager and 12 more

Abstract read
In one paragraph

Article in Medical microbiology and immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Brain, behavior, & immunity - health · 2026
    Article
  2. Article
  3. Neuroprotective and Antidepressant Effects ofExperimental neurobiology · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Anselm JordaDepartment of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Lena PracherDepartment of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Sabine EberlDepartment of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Alina Nussbaumer-PröllDepartment of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Maysa SarhanDivision of Nephrology and Dialysis, Department of Internal Medicine III, Vienna, Austria.
Maria WeberDepartment of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Markus WahrmannDivision of Nephrology and Dialysis, Department of Internal Medicine III, Vienna, Austria.
Valentin Al JalaliDepartment of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Felix BergmannDepartment of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Marlene PragerDepartment of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Amelie LeutzendorffDepartment of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Maria Sanz-CodinaDepartment of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Lara TegrovskyDepartment of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Theresa PechoDepartment of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Bernd JilmaDepartment of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Lena MüllerCore Facilities, Medical University of Vienna, Vienna, Austria.
Andreas SpittlerResearch Laboratories, Core Facility Flow Cytometry & Department of Surgery, Medical University of Vienna, Vienna, Austria.
Marianne Rocha-HaslerDepartment of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria.
Julia Eckl-DornaDepartment of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria.
Anna KusienickaDepartment of Dermatology, Medical University of Vienna, Vienna, Austria.
Matthias FarlikDepartment of Dermatology, Medical University of Vienna, Vienna, Austria.
Markus ZeitlingerDepartment of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria. markus.zeitlinger@meduniwien.ac.at.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whether the magnitude of individual cytokine, cellular, and clinical responses to the intravenous lipopolysaccharide (LPS) challenge is constant in individuals over extended time periods is unknown. Nine healthy volunteers received an intravenous LPS injection of 2 ng/kg bodyweight twice at intervals of at least one year. Circulating cytokines and leukocyte subsets were quantified using a multiplex immunoassay and cytometry by time-of-flight, respectively. Self-reported symptoms and vital signs were also assessed. We observed moderate to strong intra-individual correlations in the responsiveness of most cytokines (IL-6 [AUC

Indexed as

CytokinesLipopolysaccharidesAdultFemaleHealthy VolunteersHumansMaleMiddle AgedYoung AdultCytokinesLipopolysaccharidesEndotoxemiaEndotoxinInflammationInnate immune systemSepsis

Identifiers

PMID40047923
PMCPMC11885351

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.